Tag | Content |
---|
EnhancerAtlas ID | HS095-17040 |
Organism | Homo sapiens |
Tissue/cell | HMEC |
Coordinate | chr2:134934470-134936520 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOXC1 | MA0032.2 | chr2:134936388-134936399 | ATATTTACATA | - | 6.62 | HEY2 | MA0649.1 | chr2:134934672-134934682 | GGCACGTGTC | - | 6.02 | MEF2A | MA0052.3 | chr2:134934740-134934752 | TCTATTTATAGT | - | 6.22 | MEF2B | MA0660.1 | chr2:134934740-134934752 | TCTATTTATAGT | - | 6.37 | Npas2 | MA0626.1 | chr2:134934672-134934682 | GGCACGTGTC | + | 6.02 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_10845 | chr2:134929962-134942625 | CD20 | SE_40997 | chr2:134934171-134935743 | Left_Ventricle |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I134175 | chr2 | 134932572 | 134936372 |
|
Enhancer Sequence | TTTTTAGGCT ATAGGATGAA AGTGGTGGTT TAACAGGTCA CTGGTCTCCC GACAGGACAT 60 GTGGGACCAG GAACAGGTGC TTGTTTCTGA GCCTTTGCCC AAGTGGGTTC CCCTTAGGGC 120 TCCTTCTGGA AGGGACATGC TGCAGTTATC TCATATACCC CCTCAGCCAC CATGACCAGA 180 TATCTGACCC ACTCATTTGA AAGGCACGTG TCCTGTGATA GGGACCTCCT GTAACAAATG 240 AACCCGTGTG TGTGTGTGTG TGTATGTATC TCTATTTATA GTAATCTTGC ATCTAGTGTA 300 AGTTTTTTCT TGTTCATAGT TTTAGGTTGA TAAACAGTTC TATGGGATGG GAGGGAATGA 360 CCTCTTTAAA GAACTTCTGT AGCAACCCAG GCTTTAGGCC TTGACTTTTT GAAAACAGGT 420 TCTCTAGGTC ATCCTGCTGT AACTGTCATT CCAGCCCACA GGCCTGGGGG GATCTGATGG 480 AGGAGCCAGC ATGGAGGTTT TTAGGGCCGG GTCTGGCTGT GGTTAGCGTC ACTTTCTACT 540 CGCATTCCAT TGCCAAGAAC ACAGTCACCT GGTCACCCCT GGCAGGGAAG CGAGGTCCAG 600 CTGTGTGCCC AGGAAGATGA CAAGAGTGCG GATTTCAGTG AGTAGCTGGC ATTCCTCTCG 660 CCTGCCCTTT CCCGTTCTTC TGATTCACTG ATCAGAATCT TACTCACTAT TGCATTCTTC 720 TGTCCAAATG AACTGATTTA TTAATCTATT ACGCCTGGGC ATGATGATGG TCAGGCATGA 780 AATTTTTATG CACTGGAGTA AGAAACAATG GAAAGCAGAG AATGGAAGTT GCCTCAGAAT 840 TAATGGCCAG TGCTCATGCA GGCTCGCAGT CAGCAGCACG GAATGGCCGA TGCTGACAAT 900 GAGAGTGAAT TGGCGATGTG CCATAGGCTG CATTTGGATT TTGTTTAAAA AGTCAAGGTA 960 TTTATGAGTT GAGAGTAGTG CTCGGTTCTC AAAAAGTACA CAGCACTTAA GCAGAGGGAA 1020 ACTGCATAGG TGTATCGGTG TGAGGCCAAT TGGTAGCCCA TGATGAAATG TGGCAGAGGT 1080 AATGTAATGT GATTTAAAAA ACTTAAATAG CTGTAATATT TGCATAAGTG TGCTTTTTTT 1140 CTTCGTGCAG TGGTGAATTA AAGACAAAAC CAGTTTTGTT TTGTTTTGTT TTTTTCTCTC 1200 AAAAAAAAAA GAGGTGAGAT TTTGGGAGTG AGTTTGGGAG AGATTCTAGG CAGGAAACTT 1260 TTAGGCTGTA AAAACATCTA AAACTAAAAC TTCTAAAAAT TGCTTCTAGA GCCAGTGTTT 1320 CATAGGGCAT GAATCAGGAA AACTAGACTA GGCATTTCTA ACAGATTCTA ATACAGATAA 1380 TTGCATATTT AGGTGATGAA AGAGGAGAGT TACCAGACTG TTACAGCAAC CTAGAGATTT 1440 GTAACCTCAG GAAGATGTCC ACCCCCAGGA CTGTGGAGGC AGGGTGGTGG GGGTGGCAGC 1500 TGATGGAAAG GGCATTGGGT CCTTTGGAGA GAGCTGTCTC CCTAGAGAAG GTTATCCCAC 1560 CCAGCAAATG GAGTTGGGAG AGAGACCCAG GCACCTTCCC CTCCCAGCTT CTGATGGTAC 1620 CTCCCACAGG CCAGCACTAC TAGAAACCAG GTGGCAAGGG AGCTTGGGAA ATGTAGTTTC 1680 CTGTGATATT TGTAAAAGGA CAAAGTATGC AGAGAATGGA TTTGAGAGCA AAAAGGCAGA 1740 TGGCTGTGGC ACAAGGATTA TAACGTTGGT GCAAAGGAAG ATAAGTCGAG GAGTAAGAGA 1800 TTGCTCTAGG GAAAGAACTT GAATTCTTGA TTCCCTTCCC CCGTGCCACA TTCCTTTGTG 1860 GCTTTGTTAA CACCTGTGTC CTCTCTTCAT GTTTCTGTCA TGCTCTTTAC ACTGCATGAT 1920 ATTTACATAT TTGACTCCCT GTTAATAACT AACATTTACT GAATGTTTCC TGTGTGCTTT 1980 ATCTGCATTA ATTCATTGAC TCATCAAAGC CATCTGTGAA GGCAGGTATA GTCCATCTTC 2040 ATTATTCTCA 2050
|